potentially

AB Science announces a new publication on biorxiv that identifies AB8939 as a promising drug candidate for treating refractory acute myeloid leukemia and potentially other cancers

PRESS RELEASE AB SCIENCE ANNOUNCES A NEW PUBLICATION ON BIORXIV THAT IDENTIFIES AND CHARACTERIZES A NOVEL SMALL SYNTHETIC MOLECULE, AB8939,…

5 days ago

Frontline Performance Group Launches CheckMax with AI Insights to Maximize F&B Profits

Bigger Profits, Better Service: CheckMax Tackles Top Restaurant ChallengesĀ ORLANDO, Fla., Dec. 9, 2025 /PRNewswire/ -- Frontline Performance Group (FPG), the…

1 week ago

GT Biopharma Provides Enrollment Update on GTB-3650 Phase 1 Trial in Patients with Relapsed or Refractory (r/r) CD33 Expressing Hematologic Malignancies

The formal safety review of Cohort 3 (5ug/kg/day) has been successfully completed with no safety or tolerability issues observed, allowing…

2 months ago

Zero Trust Security Reduces Cyber Insurance Claims, Preventing up to $465 Billion Annually in Global Economic Loss from Cyber Attacks

Nearly a third of the cyber events encompassed by the study potentially could have been prevented if zero trust was…

6 months ago

Colt, Honeywell and Nokia join forces to trial space-based quantum-safe cryptography

Press ReleaseColt, Honeywell and Nokia join forces to trial space-based quantum-safe cryptography Tech collaboration will explore ways to protect encrypted…

7 months ago